Tradestie Institutional Equity Comparison Engine

EWTX vs MESO โ€” Head-to-Head Terminal

6-dimension institutional benchmarking across valuation, multi-year operating margins, normalized momentum, and dealer gamma corridors.

Market Close: 2026-11-16 Buy Verdict Report Ask Alpha

Pillar 1 Executive Scorecard & Category Winner Tally

EWTX Overall Edge

EWTX Captures Institutional Edge (4โ€“0 Pillars ยท 7โ€“1 Matrix Metrics)

Tradestie Institutional Equity Comparison Engine assigns the overall head-to-head edge to Edgewise Therapeutics, Inc. Common Stock (EWTX) driven by superior Valuation, Growth & Margin, Momentum & Technical, Options & Structure. Fundamentally, EWTX trades at N/M Forward P/E with 0.0% operating margin (+0.0% YoY revenue) versus MESO at N/M Forward P/E and -42.6% operating margin (+390.7% YoY). In options structure, EWTX sits in CONSOLIDATION (17th %ile IV; Dealer Gamma Walls on Pro) against MESO sits in UNCLASSIFIED (37th %ile IV; Dealer Gamma Walls on Pro).

Valuation Winner EWTX
EWTX N/M vs MESO N/M Fwd P/E
Growth & Margin Winner EWTX
Op Margin 0.0% vs -42.6% ยท YoY +0.0% vs +390.7%
Momentum & Technical Winner EWTX
1Y +113.6% vs -16.4% ยท 52W Pos 82% vs 6%
Options & Structure Winner EWTX
CONSOLIDATION (17th %ile IV) vs UNCLASSIFIED (37th %ile IV)
EWTX NASDAQ
Edgewise Therapeutics, Inc. Common Stock
Pharmaceutical Preparations
$43.61
-5.05% 1D
Market Cap $5.0B
1M Return +17.26%
1Y Return +113.57%
Forward P/E N/M
Unified AI Score
35.4 / 100 SELL
Tech 15.0 Fund 37.0 Flow 66.0 Mom 44.0
MESO NASDAQ
Mesoblast Limited American Depositary Shares
Biological Products, (No Diagnostic Substances)
$12.47
-6.03% 1D
Market Cap $1.7B
1M Return -6.1%
1Y Return -16.42%
Forward P/E N/M
Unified AI Score
35.5 / 100 SELL
Tech 25.0 Fund 40.0 Flow 50.0 Mom 60.0

Pillar 2 Normalized Relative Return Performance (% Indexed to 0%)

1Y Indexed Return: EWTX +113.57% MESO -16.42% Spread: +129.99 pp (EWTX Lead)

Pillar 3 Operating Profitability Benchmark (Trailing 12-Month)

Split-Invariant Revenue ($B) & Operating Margin (%)
EWTX TTM Op. Margin: 0.0% MESO TTM Op. Margin: -42.6%
Standardized multi-year USD domestic revenue schedules are unavailable for foreign-domiciled ADR filing schedules on EWTX vs MESO. Trailing 12-month operating profitability (EWTX 0.0% vs MESO -42.6%) and valuation multiples (EWTX N/M vs MESO N/M Forward P/E) are benchmarked directly in Pillar 4 below.

Pillar 4 Head-to-Head Fundamental & Valuation Matrix

Matrix Tally: EWTX (7) vs MESO (1)
Institutional Metric EWTX MESO Criterion Row Winner
Market Capitalization Scale $5.0B $1.7B Larger Scale EWTX
Trailing P/E Ratio Valuation 5.5x N/M Lower Multiple EWTX
Forward P/E Ratio Valuation N/M N/M Lower Multiple Tie
Revenue Growth (YoY) Growth +0.0% +390.7% Higher Growth MESO
Operating Margin (TTM) Profitability 0.0% -42.6% Higher Margin EWTX
Net Profit Margin Profitability 0.0% -47.8% Higher Margin EWTX
Return on Equity (ROE) Capital Efficiency 92.1% -9.9% Higher ROE EWTX
52-Week Range Position Momentum 82% ($20โ€“$49) 6% ($12โ€“$22) Stronger Trend EWTX
Beta / 30D Volatility Risk Regime 1.19ฮฒ ยท 74% Vol 1.18ฮฒ ยท 78% Vol Lower Realized Risk EWTX
Unified Institutional Score Composite Signal 35.4 / 100 (SELL) 35.5 / 100 (SELL) Higher Composite Tie

Pillar 5 Options Structure, IV Regime & Dealer Gamma Corridor

Full EWTX vs MESO Buy Guide
EWTX CONSOLIDATION
91d in phase ยท OBV ACCUMULATION
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 17th %ile
IV Regime Compressed (<25th %ile)
Live EWTX Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →
MESO UNCLASSIFIED
0d in phase ยท OBV NEUTRAL
Put Wall Floor Pro Only
Call Wall Magnet Pro Only
IV Percentile 37th %ile
IV Regime Balanced (25thโ€“60th %ile)
Live MESO Put/Call Gamma Walls & dealer positioning signals require Pro. Unlock 14-Day Free Trial →

Pillar 6 90-Day Technical & R&D Innovation Disclosures

Corporate R&D & Foundry Tracker
Neither EWTX nor MESO registered frontier semiconductor/AI engineering publications in the trailing 90-day window; head-to-head edge is anchored on operating margin trajectory, valuation multiples, and options structure above.